abdullah's picture
Add files using upload-large-folder tool
290eb2f verified
raw
history blame
48.2 kB
1
00:00:01,570 --> 00:00:07,110
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ู†ู„ุชู‚ูŠ ุงู„ูŠูˆู… ููŠ ู…ุญุงุถุฑุฉ ุฌุฏูŠุฏุฉ
2
00:00:07,110 --> 00:00:15,190
ุจุนู†ูˆุงู† myelodysplastic syndrome ูˆ myelodysplastic
3
00:00:15,190 --> 00:00:22,060
syndrome ู‡ูŠ ุนุจุงุฑุฉ ุนู† ู…ุฌู…ูˆุนุฉ ู…ู† ุงู„ู€ Disorders ุงู„ุชูŠ
4
00:00:22,060 --> 00:00:27,640
ุชุชู…ูŠุฒ ุจูˆุงุญุฏ ุฃูˆ ุฃูƒุซุฑ ู…ู† ูˆุงุญุฏ ู…ู† ุงู„ peripheral blood
5
00:00:27,640 --> 00:00:30,960
cytopenia ุดูˆ ูŠุนู†ูŠ peripheral blood cytopenia ูŠุนู†ูŠ
6
00:00:30,960 --> 00:00:37,060
ู‚ู„ุฉ ููŠ one cellular element or more cellular
7
00:00:37,060 --> 00:00:42,330
elements, and this is reflected in peripheral blood
8
00:00:42,330 --> 00:00:50,930
as ู‚ู„ุฉ/less in count ุทุจุนู‹ุง ู‡ุฐุง ุงู„ูƒู„ุงู… ู„ูŠู‡ ุฌุงู„ู‡
9
00:00:50,930 --> 00:00:53,270
secondary to bone marrow dysfunction ู„ุฃู† ุงู„ bone
10
00:00:53,270 --> 00:00:58,730
marrow ู…ุดุชุบู„ ุตุญ ุจุจุณุงุทุฉ ุงู„ bone marrow ู…ุง ุจูŠุดุชุบู„ ุตุญ
11
00:00:58,730 --> 00:01:04,610
ููŠ ุงู„ MDS ุงู„ bone marrow ู„ุง ูŠุณุชุทูŠุน ุฃู† ูŠู†ุชุฌ ุฎู„ุงูŠุง
12
00:01:04,610 --> 00:01:10,250
effectively ูŠุนู†ูŠ ุจุดูƒู„ ุณู„ูŠู…ุŒ ูˆุจุงู„ุชุงู„ูŠ ุงู„ุฎู„ุงูŠุง ุงู„ุชูŠ
13
00:01:10,250 --> 00:01:13,990
ุชุชูƒูˆู† ู‡ูŠ ุนุจุงุฑุฉ ุนู† defective cells, ุจู†ุฌูˆุณูŠู† ู‡ูŠ ุนุจุงุฑุฉ
14
00:01:13,990 --> 00:01:19,610
ุนู† ุฎู„ุงูŠุง ู…ุดูˆู‡ุฉ/ุงู„ุฎู„ุงูŠุง ุบูŠุฑ ุทุจูŠุนูŠุฉ ุงู„ุฌุณู… ุฃูˆู„ ุจุฃูˆู„
15
00:01:19,610 --> 00:01:24,630
ุจูŠุญุงูˆู„ ูŠู‚ุชู„ู„ู‡ุง/ูŠุชุฎู„ุต ู…ู†ู‡ุง ููŠ ุงู„ bone marrow ุฃูˆ ุจุนุฏ
16
00:01:24,630 --> 00:01:28,330
ุฎุฑูˆุฌู‡ุง ููŠ ุงู„ peripheral blood ุจุณุฑุนุฉ/ุจูุชุฑุฉ ู‚ุตูŠุฑุฉ
17
00:01:28,330 --> 00:01:33,210
ู…ุญุตู„ุฉ ู‡ุฐุง ุงู„ูƒู„ุงู… ู…ุฏุงู… ุงู„ุฎู„ุงูŠุง ุจุชุชูƒุณุฑุŒ ู…ุญุตู„ุฉ ู‡ุฐุง
18
00:01:33,210 --> 00:01:39,120
ุงู„ูƒู„ุงู… ุฃู†ู‡ ุจูŠุตูŠุฑ ููŠ shortage ููŠ blood cellsุŒ ูˆู‡ุฐุง
19
00:01:39,120 --> 00:01:42,940
ูŠู…ูƒู† ุฃู† ูŠุชู… ุชููƒูŠุฑู‡ ุจู€ low blood count
20
00:01:42,940 --> 00:01:46,240
characteristics
21
00:01:46,240 --> 00:01:49,560
ูƒุงู†ูˆุง ูŠุชู…ูŠุฒ ุจู€/ู‡ุฐุง ุงู„ู…ุฑุถ varying degree of
22
00:01:49,560 --> 00:01:54,940
trilineage cytopenia ุซู„ุงุซ ุฃู†ูˆุงุน ู…ู† ุงู„ุฎู„ุงูŠุง RBCs
23
00:01:54,940 --> 00:02:01,040
ูˆWBCs ูˆPlatelets dysplasia ุชุดูˆู‡ุงุช normocellular or
24
00:02:01,040 --> 00:02:06,460
hypercellular bone marrow ูˆู‡ุฐู‡ ุงู„ู…ุฑุถูŠุฉ ู‚ุฏ ุชุชุทูˆุฑ ุฅู„ู‰
25
00:02:06,460 --> 00:02:11,020
ุฃูƒูŠุฏู„ูˆูƒูŠู…ูŠุง ู…ู…ูƒู† ูŠู‚ู„ุจ ุจุจุณุงุทุฉ ู„ู€ ุงูƒูŠูˆุช ู„ูˆูƒูŠู…ูŠุง
26
00:02:11,020 --> 00:02:14,860
Symptoms, signs and symptoms ุทุจูŠุนูŠ ุฌุฏู‹ุง ููŠ ุงู„ bone marrow
27
00:02:14,860 --> 00:02:20,480
failure ูˆุจุงู„ุชุงู„ูŠ ููŠ ุงู†ูŠู…ูŠุง ูˆู†ูŠูˆุชุฑูˆุจูŠู†ูŠุง ูˆุงู†ููƒุดู†
28
00:02:20,480 --> 00:02:25,760
ูุงู„ุงู†ูŠู…ูŠุง is manifested by excessive tiredness
29
00:02:25,760 --> 00:02:31,040
shortness of breath, pale skin that is correlated
30
00:02:31,040 --> 00:02:35,790
with anemiaุŒ ูˆู‡ูŠ ุนุจุงุฑุฉ ุนู† shortage of RBCs ูˆุงู„ู€
31
00:02:35,790 --> 00:02:39,510
neutropenia ุฃูˆ ุงู„ู€ infection serious infection ู…ุน
32
00:02:39,510 --> 00:02:44,330
high fever that also can be caused by leukopenia
33
00:02:44,330 --> 00:02:50,150
ุจู…ุนู†ู‰ ุฃู† ู…ุง ููŠุด white blood cells ูƒูุงูŠุฉ ูˆุจุงู„ุฐุงุช ุงู„ู€
34
00:02:50,150 --> 00:02:58,650
neutrophils ูˆุจุงู„ุชุงู„ูŠ ููŠ few mature granulocytes ูˆุงู„ู€
35
00:02:58,650 --> 00:03:03,470
excessive bruising ุงู„ู„ูŠ ู‡ูˆ ู…ุงุดูŠ ู…ุน/ุทุจุนู‹ุง ุจูŠุตูŠุฑ
36
00:03:03,470 --> 00:03:06,270
ููŠู‡ severe nose bleeding ุฃูˆ bleeding from the
37
00:03:06,270 --> 00:03:10,930
gums that can be due to thrombocytopenia ุจู…ุนู†ู‰ ุฃู†ู‡
38
00:03:10,930 --> 00:03:16,290
ู…ุง ููŠุด platelets ูƒูุงูŠุฉ ููŠ ุงู„ุฌุณู… ุนุดุงู† to plug the holes
39
00:03:16,290 --> 00:03:21,530
in damaged blood vessels incidence ู‡ุฐุง ุนุจุงุฑุฉ ุนู†
40
00:03:21,530 --> 00:03:24,790
disease of elderly people median age ุฎู…ุณุฉ ูˆุณุชูŠู†
41
00:03:24,790 --> 00:03:30,850
ุณู†ุฉ ุฅุฐุง ูƒุงู† ูƒุงู†
42
00:03:30,850 --> 00:03:36,380
ุทุจุนู‹ุง ููŠ ุฃู‚ู„ ู…ู† 10% ู…ู† ุงู„ุญุงู„ุงุช ุจูŠูƒูˆู†ูˆุง ููŠ ุฃู‚ู„ ู…ู† 50
43
00:03:36,380 --> 00:03:42,520
ุณู†ุฉุŒ ูˆุจุงู„ุชุงู„ูŠ ุงู„ incidence rate ุจุชูƒูˆู† ูˆุงุญุฏ ู„ูƒู„ 100
44
00:03:42,520 --> 00:03:49,820
ุฃู„ู ููŠ ุงู„ population ู„ูƒู†ู‡ุง ุชุฒูŠุฏ ุฅู„ู‰ ูˆุงุญุฏ ู„ูƒู„ ุฃู„ู
45
00:03:49,820 --> 00:03:53,900
ู…ู† ุงู„ population ููŠ ุงู„ุฃุนู…ุงุฑ ุงู„ูƒุจูŠุฑุฉ ุงู„ู„ูŠ ู‡ูŠ ุฃูƒุจุฑ
46
00:03:53,900 --> 00:03:58,360
ู…ู† 60 ุณู†ุฉุŒ ูˆุงู„ male is slightly higher than female
47
00:03:59,910 --> 00:04:04,490
ุฃุณุจุงุจ ุญุทูˆุง ุณุจุจุจู† ู„ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ูƒุงู†ูˆุง ููŠู‡ ู†ูˆุนูŠู† ู…ู†
48
00:04:04,490 --> 00:04:09,330
ุงู„ MDS ู†ูˆุน ุจูŠุณู…ูˆู‡ de novo ุงู„ู„ูŠ ู‡ูˆ ุงู„ุฃุตู„ูŠ/ุงู„ุฃุณุงุณูŠ
49
00:04:09,330 --> 00:04:11,930
ูˆุงู„ู„ูŠ ุบุงู„ุจู‹ุง associated with benzene exposure
50
00:04:11,930 --> 00:04:16,410
cigarette smoking and viruses ูˆููŠ ู†ูˆุน ู…ู†ู‡
51
00:04:16,410 --> 00:04:20,830
congenital ุจูŠุณู…ูˆู‡ Fanconi's anemia ู†ูˆุน ู…ู† ุงู„
52
00:04:20,830 --> 00:04:25,010
congenital disease ุจูŠุณู…ูˆู‡ุง Fanconi's anemia sorry
53
00:04:25,010 --> 00:04:29,810
ู‡ุฐุง aplastic anemia ุงู„ู†ูˆุน ุงู„ุซุงู†ูŠ ู‡ูˆ therapy related
54
00:04:29,810 --> 00:04:32,970
ูˆ therapy induced and usually associated with
55
00:04:32,970 --> 00:04:37,270
alkylating agents, chemotherapy or radiation ุจูŠุญุตู„
56
00:04:37,270 --> 00:04:42,970
ู†ุชูŠุฌุฉ ุฃุฎุฐ ุงู„ู…ุฑูŠุถ ู‡ุฐู‡ ุงู„ูƒูŠู…ูŠุงุก ุฏูŠ/ู‡ุฐู‡ ุงู„ู…ูˆุงุฏ
57
00:04:42,970 --> 00:04:49,030
ุงู„ูƒูŠู…ูŠุงุฆูŠุฉ ูˆ ู‡ุฐู‡ ุงู„ุนู„ุงุฌุงุช ุจูŠุตูŠุฑ ููŠ ุนู†ุฏู‡ MDS ู‡ุฐู‡ ุตูˆุฑุฉ
58
00:04:49,030 --> 00:04:55,170
ุฌูŠุฏุฉ ุฌุฏุง ุจุชูˆุถุญ ู„ู†ุง ุฃูˆ ุจุชูู‡ู…ู†ุง ุจุงู„ุถุจุท ุฃู†ูˆุงุน ุงู„ู„ูŠ ู‡ูˆ
59
00:04:55,850 --> 00:04:59,790
ุงู„ู€ hematological malignancies ุฅุฐุง ูู‡ู…ู†ุงู‡ุง ุจู†ูู‡ู…
60
00:04:59,790 --> 00:05:06,750
ุจู†ู‚ุฏุฑ ู†ุนุฑู ุชู‚ุณูŠู…ุชู‡ุง ู„ุฃู†ู‡ ุจูŠูˆุถุญ ุงู„ู„ูŠ ู‡ูˆ ุฃุฐุฑุน ุฃูˆ
61
00:05:06,750 --> 00:05:13,350
ุฃุฐุฑุน ุงู„ hemapoiesis ูƒู†ุง ุจู†ุนุฑู ุฃู† ุงู„ stem cell ุจ
62
00:05:13,350 --> 00:05:18,750
... ูƒุงู† proliferate ูŠุนู†ูŠ ุงู„ุฃุฐุฑุน ุงู„ู…ุทู„ูˆุจูŠู†
63
00:05:18,750 --> 00:05:22,610
proliferation ูˆ differentiation ู…ุงุดูŠ
64
00:05:25,890 --> 00:05:32,110
ูููŠ ุงู„ MDS ุงู„ุฎู„ู„ ุจูŠูƒูˆู† ููŠ ุงู„ differentiation
65
00:05:32,110 --> 00:05:37,590
ูˆุจุงู„ุชุงู„ูŠ ุงู„ู…ุญุตู„ุฉ ู„ุฅูŠุดุŸ ู‡ูŠ dysplastic form of cells
66
00:05:37,590 --> 00:05:43,710
ูˆุจู…ุง ุฃู† ุงู„ุฎู„ู„ ููŠ ูƒู„ ุฃู†ูˆุงุน ุงู„ุฎู„ุงูŠุง ูŠุจู‚ู‰ ุจูŠุตูŠุฑ ููŠู‡
67
00:05:43,710 --> 00:05:49,650
trilineage cytopenia ุจูŠู†ู…ุง ู„ูˆ ูƒุงู† ุงู„ุฎู„ู„ ููŠ ุฐุฑุงุน
68
00:05:49,650 --> 00:05:53,550
ุงู„ proliferation ุจุชุนู…ู„ ู…ุฑุถ ุจูŠุณู…ูˆู‡ ุงู„ู„ูŠ ู‡ูˆ Non
69
00:05:53,550 --> 00:05:58,790
Leukemic Myeloproliferative Diseases ูˆ ู„ูˆ ูƒุงู† ุงู„ุฎู„ู„ ููŠ
70
00:05:58,790 --> 00:06:05,650
ุงู„ุฃุฐุฑุน ุจุงู„ุฅุถุงูุฉ ุฅู„ู‰ dominance of mutant cell type ูŠุนู†ูŠ ููŠ
71
00:06:05,650 --> 00:06:11,230
prominent cell type which
72
00:06:11,230 --> 00:06:15,050
is dominant ุจูŠุชูƒูˆู†
73
00:06:15,050 --> 00:06:18,970
ุงู„ุญุงู„ุฉ Leukemia ูŠู…ูƒู† ููŠ ุงู„ Leukemia ุงู„ุฃุฐุฑุน
74
00:06:18,970 --> 00:06:31,500
ู…ุถุฑูˆุจูŠู†ุŒ ูˆู‡ูŠ ููŠู‡ mutant genes ููŠ ุงู„ MDS ุงู„ุฐุฑุงุน ุงู„
75
00:06:31,500 --> 00:06:34,880
differentiation ุจูŠูƒูˆู† ู…ุถุฑูˆุจ ููŠ ุงู„ non-leukemic
76
00:06:34,880 --> 00:06:38,440
myeloproliferative disorders ุงู„ proliferation ุจูŠูƒูˆู†
77
00:06:38,440 --> 00:06:39,420
ู…ุถุฑูˆุจ
78
00:06:41,880 --> 00:06:45,460
ุทุจุนู‹ุง ุงู„ู€ Etiological agents ุนู†ุฏู‡ ู‚ุงุฆู…ุฉ ุทูˆูŠู„ุฉ ูˆุนุฑูŠุถุฉ
79
00:06:45,460 --> 00:06:49,480
ุฌุฏุงู‹ ู…ู…ูƒู† ุชูƒูˆู† ุณุจุจ ู„ู‡ุฐู‡ ุงู„ุฃู…ุฑุงุถ/ู„ู‡ุฐุง ุงู„ู…ุฑุถ ุฒูŠ ุงู„ู€
80
00:06:49,480 --> 00:06:52,000
tobacco, ionizing radiation, organic chemicals
81
00:06:52,000 --> 00:06:57,180
ุจุฃู†ูˆุงุนู‡ุงุŒ heavy metals, herbicides ูˆ pesticides ูˆ
82
00:06:57,180 --> 00:07:00,980
fertilizers ุจู…ุฌู…ูˆุนุฉ ูƒุซูŠุฑุฉ ู…ู† ุงู„ alkylating agents ูˆ
83
00:07:00,980 --> 00:07:07,340
petroleum ูˆ ู‡ูƒุฐุง ุทุจุนู‹ุง ู‡ุฐุง ู…ุญุตู„ุชู‡ ูƒู€ chromosome
84
00:07:07,340 --> 00:07:11,060
abnormality ูˆุณุฌู„ุช ุญุงู„ุงุช chromosome abnormality ููŠ
85
00:07:11,060 --> 00:07:15,380
ุฃูƒุซุฑ ู…ู† 50% ู…ู† ุงู„ุญุงู„ุงุช ูˆููŠ ุญูˆุงู„ูŠ ูƒู„ ุญุงู„ุงุช
86
00:07:15,380 --> 00:07:21,580
ุงู„ secondary ุฃูˆ ุงู„ therapy related MDS ุทุจุนู‹ุง ู‡ุฐู‡
87
00:07:21,580 --> 00:07:26,700
ุนุจุงุฑุฉ ุนู† ุฃู…ุซู„ุฉ ูู‚ุท ู„ุญุงู„ุงุช ุงู„ chromosome ุงู„
88
00:07:26,700 --> 00:07:30,660
abnormality ุงู„ู„ูŠ ุจุชุชุตุงุญุจ ุฃูˆ ุจุชูƒูˆู† ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ MDS
89
00:07:30,660 --> 00:07:37,120
ูู‡ูŠ ุฒูŠ ู…ุง ุฃู†ุชู… ุดุงูŠููŠู† 5q minus ู…ุงุดูŠ 7q
90
00:07:37,120 --> 00:07:45,490
11q ู…ู†ุธูˆู…ุฉ/ูƒุฐุง ุนุฏุฏ ูƒุจูŠุฑุฉ ู…ู† chromosome
91
00:07:45,490 --> 00:07:48,550
abnormality ุทุจุนู‹ุง ู…ู† ุฃุดู‡ุฑู‡ุง deletion of the long
92
00:07:48,550 --> 00:07:57,010
arm of chromosome 5 5q minus syndrome ูˆุญุชู‰
93
00:07:57,010 --> 00:08:06,490
ุงู„ูŠูˆู… ููŠ ูŠุนู†ูŠ ู†ูˆุน ุงุณู…ู‡ 5q minus syndrome ุฃูˆ 5q
94
00:08:06,490 --> 00:08:12,800
minus MDS ู‡ูˆ ู…ุฑุชุจุท ุจุดูƒู„ ูƒุจูŠุฑ ุจู€ refractory anemia with
95
00:08:12,800 --> 00:08:14,580
ring sideroblasts
96
00:08:18,460 --> 00:08:22,520
ูˆูŠุดูƒู„ ุญูˆุงู„ูŠ 70% ู‡ุฐุง ุงู„ู€ cytogenetic abnormality
97
00:08:22,520 --> 00:08:27,520
of this type ุทุจุนู‹ุง ููŠ ู…ู†ุทู‚ุฉ ุงู„ู€ q arm of chromosome
98
00:08:27,520 --> 00:08:32,220
number 7 ูˆุฌุฏูˆุง ุฃู†ู‡ ููŠ ู…ุนุธู… ุงู„ุฌูŠู†ุงุช ุงู„ู„ูŠ ู…ุณุคูˆู„ุฉ ุนู†ู‡ู…
99
00:08:32,220 --> 00:08:35,980
growth and growth factors ูˆุจุงู„ุชุงู„ูŠ ุบูŠุงุจู‡ุง ู…ุนู†ุงุชู‡
100
00:08:35,980 --> 00:08:40,440
ู…ุง ููŠุด growth factors ุฒูŠ IL 3 ุฃูˆ 4 ุฃูˆ 5 ุฃูˆ GM-CSF ูˆ
101
00:08:40,440 --> 00:08:46,190
M-CSF ูˆุจุงู„ุชุงู„ูŠ ุงู„ receptors ุฃูŠุถู‹ุง ูƒู…ุงู† ุบุงุฆุจุฉ ู„ุฃู† ู‡ูˆ
102
00:08:46,190 --> 00:08:50,090
gene and receptor for growth factors and their receptors
103
00:08:50,090 --> 00:08:55,910
ูˆุจุงู„ุชุงู„ูŠ ุทุจุนู‹ุง ูู‚ุฏ ู‡ุฐู‡ ุงู„ู…ูˆุงุฏ ู‡ูŠุคุฏูŠ ุฅู„ู‰
104
00:08:55,910 --> 00:09:01,810
disruption or overdraft of hemopoiesis
105
00:09:01,810 --> 00:09:09,190
monosomy 7 and 7q- ุฃูŠุถู‹ุง associated with secondary
106
00:09:09,190 --> 00:09:16,490
MDS ูˆูŠูˆุฌุฏูˆุง ููŠ ู‡ุฐู‡ ุงู„ู…ู†ุทู‚ุฉ ููŠ ุงู„ major surface
107
00:09:16,490 --> 00:09:23,750
glycoprotein 130 ูˆุจุงู„ุชุงู„ูŠ ุบูŠุงุจู‡ ู…ุนู†ุงุชู‡ ููŠ ุบูŠุงุจ ู„ู€
108
00:09:23,750 --> 00:09:26,710
neutrophil function and susceptibility to
109
00:09:26,710 --> 00:09:29,930
bacterial infections ุบุงู„ุจู‹ุง ู„ุฃู†
110
00:09:29,930 --> 00:09:34,870
ุงู„ granulocyte chemotactic activity is defected
111
00:09:34,870 --> 00:09:39,310
11q- deletion of 11q
112
00:09:41,750 --> 00:09:46,730
ูŠุดูƒู„ ู‡ุฐุง ุญูˆุงู„ูŠ 20% ู…ู† ุญุงู„ุงุช refractory
113
00:09:46,730 --> 00:09:50,630
anemia with ringed sideroblasts ูˆ ู„ุณู‡ abnormality
114
00:09:50,630 --> 00:09:55,030
ุบุงู„ุจู‹ุง associated with raised iron stores ุชู„ุงู‚ูŠ ุงู„ู€
115
00:09:55,030 --> 00:09:58,250
iron stores ุนุงู„ูŠุฉ ูˆ ุจูŠุตูŠุฑ ููŠู‡ุง ringed sideroblasts
116
00:09:58,250 --> 00:10:06,030
ุงู„ุณุจุจ ููŠ ุฐู„ูƒ ูˆุฌูˆุฏ ุงู„ุฌูŠู† ุงู„ู…ุณุคูˆู„ ุนู† ุงู„ H subunit of
117
00:10:06,030 --> 00:10:12,510
ferritin ููŠ ู‡ุฐู‡ ุงู„ู…ู†ุทู‚ุฉ ูˆุนู„ู‰ chromosome ุฑู‚ู… 11 ูˆุฐู„ูƒ
118
00:10:12,510 --> 00:10:21,150
ุฃูŠุถู‹ุง ู…ุง ูŠูุณุฑ ุฒูŠุงุฏุฉ iron store abnormality ููŠ
119
00:10:21,150 --> 00:10:28,830
chromosome 17 ุทุจุนู‹ุง inversion of 17q ู‚ุงู„ูˆุง ููŠ ู‡ุฐู‡
120
00:10:28,830 --> 00:10:35,310
ุงู„ู…ู†ุทู‚ุฉ ูŠูˆุฌุฏ ุงู„ p53 ุฃูˆ tumor suppressor gene ุงู„ู„ู‰
121
00:10:35,310 --> 00:10:42,420
ู…ูˆุฌูˆุฏ ููŠ ูƒุซูŠุฑ ู…ู† ุงู„ุญุงู„ุงุช ู…ู† ุงู„ AML ุจุงู„ุฐุงุช
122
00:10:42,420 --> 00:10:46,520
ู„ู…ุง ุชูŠุฌูŠ ููŠ ุงู„ blast phase ู…ู† ุงู„ plastic phase ู…ู† ุงู„
123
00:10:46,520 --> 00:10:53,480
chronic phase ู„ู€ ุงู„ blast phase ูˆ ุชู‚ุฑูŠุจู‹ุง ุญูˆุงู„ูŠ 5%
124
00:10:53,480 --> 00:11:03,680
ู…ู† ุญุงู„ุงุช ุงู„ primary MDS ุทุจุนู‹ุง ู‡ุฐุง ุจูŠุฏูŠ ุฅู„ู‰ dysplastic
125
00:11:03,680 --> 00:11:06,660
features of cells and neutrophil
126
00:11:06,660 --> 00:11:13,510
vacuolization abnormality ููŠ chromosome 3 ุจุนู…ู„ mega
127
00:11:13,510 --> 00:11:20,210
karyocytes ูˆthrombocytosis ูˆู‡ุฐุง ุบุงู„ุจู‹ุง ู…ุตุญูˆุจ ุจู‡ุฐุง
128
00:11:20,210 --> 00:11:25,230
ุงู„ abnormality ุทูŠุจ ุดูˆููˆุง ุฃู‡ู…ูŠุฉ/importance of
129
00:11:25,230 --> 00:11:28,670
indication of chromosome abnormality ูŠู‚ูˆู„ ุฑู‚ู… ูˆุงุญุฏ
130
00:11:28,670 --> 00:11:32,270
to confirm diagnosis ุฑู‚ู… ุงุซู†ูŠู† to know the stage
131
00:11:32,270 --> 00:11:36,090
of disease ุฑู‚ู… ุซู„ุงุซ to know the direction of
132
00:11:36,090 --> 00:11:41,420
progression of disease ุชุทูˆุฑ ุงู„ุญุงู„ุฉ ุงู„ู…ุฑุถูŠุฉ ุฑู‚ู…
133
00:11:41,420 --> 00:11:45,440
ุฃุฑุจุนุฉ Multiple Genetic Abnormalities ู…ุนู†ุงุชู‡ ุงู„ู…ุฑูŠุถ ููŠ
134
00:11:45,440 --> 00:11:53,760
ู…ุฑุงุญู„ู‡ ุงู„ู…ุชุฃุฎุฑุฉ Pattern of MDS Evolution ูƒูŠู ูŠุชุทูˆุฑ
135
00:11:53,760 --> 00:11:59,340
ู‡ุฐุง ุงู„ู…ุฑุถ ูˆู…ุฑุงุญู„ ุชุทูˆุฑู‡ ุฌุงูŠุจูˆุง ูŠุจุฏุฃ ุจ stable group
136
00:11:59,340 --> 00:12:02,840
with no increase in bone marrow blasts
137
00:12:08,420 --> 00:12:10,240
ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช
138
00:12:10,240 --> 00:12:16,340
ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ
139
00:12:16,340 --> 00:12:19,840
ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช
140
00:12:19,840 --> 00:12:20,040
ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช
141
00:12:20,040 --> 00:12:20,660
ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช
142
00:12:20,660 --> 00:12:23,100
ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ
143
00:12:23,100 --> 00:12:27,720
ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ ูˆุงู„ุฎู„ุงูŠุง ูƒุงู†ุช
144
00:12:27,720 --> 00:12:33,370
ู…ุถุฑูˆุจุฉ ูˆู„ูƒู† ู…ุณุชู‚ู„ุฉ .. ู†ู…ุฑุฉ ุชู„ุงุชุฉ ุจูŠุตูŠุฑ ููŠ ุฒูŠุงุฏุฉ ููŠ
145
00:12:33,370 --> 00:12:38,630
ุงู„ blast count ูˆ .. ุทุจุนุง ุญุชู‰ ููŠ ุบูŠุงุจ ุงู„
146
00:12:38,630 --> 00:12:43,310
cytogenetic changes ูˆ ู‡ุฐุง ู‡ูŠ ุงู„ู…ุฑุงุญู„ ุงู„ู…ุฎุชู„ูุฉ ุฏู‡
147
00:12:43,310 --> 00:12:47,370
ู‡ูŠ normal stem cell ู„ูƒู†ู‡ุง ุชุนุฑุถุช ู„ insult ูˆู…ู† ุงู„
148
00:12:47,370 --> 00:12:51,610
insult genetic insult ู…ู…ูƒู† ูŠูƒูˆู† age or viral or
149
00:12:51,610 --> 00:12:58,690
chemical or radiochemical ู…ุงุฐุง ูŠุญุตู„ุŸ ูŠุญุตู„ ููŠู‡
150
00:12:58,690 --> 00:13:02,910
Stable New Abnormal Clone Clue abnormal ู„ูƒู†ู‡ุง
151
00:13:02,910 --> 00:13:05,990
ู…ุงุฒุงู„ุช ู…ุณุชู‚ู„ุฉ ูŠุนู†ูŠ ุงู„ู…ุฑูŠุถ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุจูŠูƒูˆู†
152
00:13:05,990 --> 00:13:12,090
hematologically silent ุฅุฐุง ุงุชุนุฑุถุช ุงู„ุฌูŠู†ุงุช ู„ู„ู€
153
00:13:12,090 --> 00:13:16,550
mutation ูŠุญุตู„ ููŠ growth advantage ูˆ ูŠุฏุฎู„ ุงู„ู…ุฑูŠุถ ููŠ
154
00:13:16,550 --> 00:13:20,420
ู…ุฑุญู„ุฉ ุจูŠุณู…ูˆู‡ุง pre-leukemic status ู„ูˆ ูุญุตู†ุง ุงู„
155
00:13:20,420 --> 00:13:24,220
karyotype ููŠ ู‡ุฐู‡ ุงู„ู…ุฑุญู„ุฉ ุจูŠู„ุงู‚ูŠู‡ุง abnormal ูŠุนู†ูŠ
156
00:13:24,220 --> 00:13:27,740
ู‚ุจู„ ู‡ูŠูƒ ุจูŠูƒูˆู† normal ุฃูˆ ู†ุนู… ู‚ุจู„ ู‡ูŠูƒ ุจูŠูƒูˆู† normal
157
00:13:27,740 --> 00:13:33,720
ุทุจุนุง once the karyotype is abnormal ูŠุนู†ูŠ ููŠู‡
158
00:13:33,720 --> 00:13:36,720
chromosomal abnormality ุจูŠุตูŠุฑ ููŠู‡ inhibition
159
00:13:36,720 --> 00:13:41,920
ู„ู€ normal hemopoiesis ูˆุชู†ุชู‡ูŠ ุบุงู„ุจุง ู…ู†ู‡ุง ุจุชุฌู„ุจ ู„ู…ูŠู†ุŸ
160
00:13:41,920 --> 00:13:45,360
ู„ู„ู„ูˆูƒูŠู…ูŠุง ุจุชุฌู„ุจ ู„ู„ู„ูˆูƒูŠู…ูŠุง ุจูŠุตูŠุฑ ููŠ ูู„ุงู† ู„ูˆูƒูŠู…ูŠุง
161
00:13:45,360 --> 00:13:50,320
clone is produced ูŠุจู‚ู‰ ู‡ุฐู‡ ู‡ูŠ ุงู„ู…ุฑุงุญู„ ุงู„ู…ุฎุชู„ูุฉ
162
00:13:50,320 --> 00:13:54,920
Normal stem cell ุชุนุฑุถุช ู„ install ุชูƒูˆูŠู† new
163
00:13:54,920 --> 00:13:58,580
abnormal clone ู„ูˆ ูุญุตู†ุง ุงู„ proto-oncogene ุฃูˆ ุงู„
164
00:13:58,580 --> 00:14:02,820
ุฌูŠู†ุงุช ุจูŠูƒูˆู† by karyotyping sorry ู„ู„ูƒุฑูˆู…ูˆุณูˆู…ุงุช by
165
00:14:02,820 --> 00:14:05,860
karyotyping ุจุชูƒูˆู† normal ูˆู…ุงููŠ blast cell ููŠ ู‡ุฐู‡
166
00:14:05,860 --> 00:14:09,300
ุงู„ุญุงู„ุฉ ู„ูƒู† once a mutation is occurred ุจูŠุตูŠุฑ ููŠ
167
00:14:09,300 --> 00:14:12,960
growth advantage ุจูŠุฎุด ุงู„ู…ุฑูŠุถ ููŠ preleukemic status
168
00:14:12,960 --> 00:14:16,690
ู„ูˆ ูุญุตู†ุง ุงู„ karyotyping ุนู„ู‰ ุฌู‡ุฉ abnormal ู…ุชู‰ ู…ุง
169
00:14:16,690 --> 00:14:19,870
ุตุงุฑุช abnormal ูŠุนู†ูŠ ููŠู‡ ู†ู‡ุจุด ู„ู€ normal hemopoiesis
170
00:14:19,870 --> 00:14:25,550
ูŠุนู†ูŠ ุงู„ู„ูŠ ููŠ ุงู„ุบุงู„ุจ ุชุฌู„ุจ ู„ู„ู„ูˆูƒูŠู…ูŠุง classification
171
00:14:25,550 --> 00:14:30,910
of FAP ู‚ุณู…ูˆู‡ุง ุฅู„ู‰ ุฎู…ุณ ุฃู†ูˆุงุน ู…ุฎุชู„ูุฉ ู‡ุฐุง ุงู„ุฌุฏูˆู„
172
00:14:30,910 --> 00:14:35,470
ุจู„ุฎุตู†ุง ุงู„ุฃู†ูˆุงุน ุงู„ู…ุฎุชู„ูุฉ ูƒู„ู‡ุง ุงู„ู„ูŠ ุฅู† ุดุงุก ุงู„ู„ู‡
173
00:14:35,470 --> 00:14:40,310
ุจู†ุฌูŠู‡ุง ุจุงู„ุชูุตูŠู„ ู‚ุฏุงู…ูŠ ุจุณ ู‡ุฐุง ุงู„ุฌุฏูˆู„ ู…ู‡ู… ู…ุงุดูŠ ุฅูŠุด
174
00:14:40,310 --> 00:14:43,860
ุจูŠู‚ูˆู„ ุงู„ุฃู†ูˆุงุน ู‡ูŠ ุฎู…ุณ ุฃู†ูˆุงุน Refractory Anemia
175
00:14:43,860 --> 00:14:46,180
Refractory Anemia with Ringed Sideroblast
176
00:14:46,180 --> 00:14:48,800
Refractory Anemia with Excess Blasts ู‡ุงูŠ
177
00:14:48,800 --> 00:14:51,780
ุงู„ุงุฎุชุตุงุฑุงุช Refractory Anemia with Excess Blasts
178
00:14:51,780 --> 00:14:52,700
and Transformation Refractory Anemia with
179
00:14:52,700 --> 00:14:53,860
Excess Blasts and Transformation and Chronic
180
00:14:53,860 --> 00:14:55,400
Myelomonocytic Leukemia
181
00:15:04,420 --> 00:15:08,400
ู†ู‚ุฏุฑ ู†ุดูˆู ุงู„ู€ Blast ููŠ ุงู„ู€ Peripheral Blood ูˆุงู„ู€
182
00:15:08,400 --> 00:15:11,580
Bone Marrow ุซู… ู†ุดูˆู ุงู„ู€ Monocytes ู„ุฅู†ู‡ ููŠ ุงู„ู†ูˆุน
183
00:15:11,580 --> 00:15:16,160
ููŠู‡ ุงู„ู€ Monocytes ุซู… Ringed Sideroblast ู„ุฅู†ู‡ ููŠ
184
00:15:16,160 --> 00:15:19,560
ุงู„ู†ูˆุน ุจูŠุตูŠุฑ ููŠู‡ Ringed Sideroblast ูˆู†ุดูˆู ุฅุฐุง ูƒุงู†
185
00:15:19,560 --> 00:15:24,000
ููŠู‡ other features can be compared ูุงู„ู€ Refractor
186
00:15:24,000 --> 00:15:26,560
ูŠู‚ูˆู„ ุฅู† ุงู„ู€ Blast ููŠ ุงู„ Peripheral Blood ูŠูƒูˆู† ุฃู‚ู„
187
00:15:26,560 --> 00:15:29,580
ู…ู† ูˆุงุญุฏ ููŠ ุงู„ Bone Marrow ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ูˆุฃู†ุง ูˆุงุญุฏุฉ
188
00:15:29,580 --> 00:15:35,750
ุนุจุงุฑุฉ ุนู† Normal Percentage ุงู„ู†ุณุจุฉ ุฃู‚ู„ ู…ู† ูˆุงุญุฏ ุงู„
189
00:15:35,750 --> 00:15:40,090
ringed sideroblast ุจุชูƒูˆู† ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ุนุดุฑ ูˆูŠูƒูˆู† ุงู„ู…ุฑูŠุถ
190
00:15:40,090 --> 00:15:44,870
ุนู†ุฏู‡ ุฃู†ูŠู…ูŠุง ุฅู†ู‡ุง ุงู„ู„ูŠ associated with ูŠุนู†ูŠ ุงู„ู„ูŠ
191
00:15:44,870 --> 00:15:48,910
ุจูŠุดุจู‡ู‡ ุฃูˆ ุชุทูˆุฑู‡ ุงู„ู„ูŠ ู‡ูˆ ุงู„ู†ูˆุน ุงู„ุซุงู†ูŠ ุงู„ู„ูŠ ู‡ูˆ
192
00:15:48,910 --> 00:15:53,100
refractory anemia ูˆ ringed sideroblast ุงู„ู€ blast ูŠูƒูˆู†
193
00:15:53,100 --> 00:15:55,720
ุฃู‚ู„ ู…ู† ูˆุงุญุฏ ููŠ ุงู„ู€ peripheral blood ูˆุฃู‚ู„ ู…ู† ุฎู…ุณุฉ
194
00:15:55,720 --> 00:15:59,840
ููŠ ุงู„ู€ bone marrow ูŠุนู†ูŠ still ุงู„ blast ู„ู… ูŠุชูƒูˆู† monocyte
195
00:15:59,840 --> 00:16:05,360
ุฃูŠุถุง ูƒุฐู„ูƒ ู„ูƒู† ุงู„ู„ูŠ ุจูŠู…ูŠุฒู‡ุง ูˆุฌูˆุฏ ringed sideroblast
196
00:16:05,360 --> 00:16:09,980
ุงุณู…ู‡ุง with ringed sideroblast ู…ุงุดูŠุŸ ูŠุนู†ูŠ ููŠ ุฒูŠุงุฏุฉ
197
00:16:09,980 --> 00:16:15,340
ููŠ ุฅูŠุดุŸ ููŠ ุงู„ iron ู‡ูˆ ุทุจุนุง ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุจูŠูƒูˆู† ููŠ
198
00:16:15,340 --> 00:16:22,800
Anemia ูˆููŠ Refractory Cytopenia ู„ุดูŠุก ุจุชุฏูŠ ุนู„ุงุฌ ู„ุง
199
00:16:22,800 --> 00:16:27,740
ูŠุณุชุฌูŠุจ Refractory Anemia ูˆ Excessive Blasts ู‡ูŠ ุจุฏุช
200
00:16:27,740 --> 00:16:31,160
ุชุฒูŠุฏ ุงู„ blast ูŠุนู†ูŠ ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ููŠ ุงู„ peripheral
201
00:16:31,160 --> 00:16:35,880
blood ู…ู† ุฎู…ุณุฉ ู„ุนุดุฑูŠู† ููŠ ุงู„ bone marrow ูŠุนู†ูŠ ู„ุณู‡
202
00:16:35,880 --> 00:16:40,280
ู…ุงูˆุตู„ุช ู„ุซู„ุงุซูŠู† ู…ุง ู†ู‚ุฏุฑุด ู†ุณู…ูŠู‡ leukemia ูˆุฃู‚ู„ ู…ู† ูˆุงุญุฏ
203
00:16:40,280 --> 00:16:45,440
ุงู„ monocyte ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ุนุดุฑ ุงู„ู€ Sidroblast ูˆุงู„
204
00:16:45,440 --> 00:16:49,960
ุงู„ุฃู†ูŠู… .. ูˆุงู„ .. ุงู„ .. ุทุจุนุง ุงู„ other feature ุงู„ู„ูŠ
205
00:16:49,960 --> 00:16:54,000
ู‡ูˆ Cytopenia ูˆ Refractory Anemia ูˆุงู„ุดุบู„ุงุช ู‡ุฐู‡
206
00:16:54,000 --> 00:16:58,640
ุงู„ุฑุงุจุน ุงู„ู„ูŠ ู‡ูˆ Refractory Anemia ูˆ Excess
207
00:16:58,640 --> 00:17:03,780
Blasts in Transformation ุฅูŠุด ูŠุนู†ูŠุŸ ุจุฏุช ุชู‚ู„ุจ ูุดูู†ุง
208
00:17:03,780 --> 00:17:08,250
ุงู„ blast ููŠ ุงู„ peripheral ุฃูƒุชุฑ ู…ู† ุฎู…ุณุฉ ุจุนุฏ ุชุฌุฑุจุฉ
209
00:17:08,250 --> 00:17:12,590
ุงู„ู€ bone marrow ู…ู† ุนุดุฑูŠู† ู„ุซู„ุงุซูŠู† ูŠุนู†ูŠ ุชู‚ุฑูŠุจุง ู„ูƒูŠู…ูŠุง
210
00:17:12,590 --> 00:17:17,650
ุชู‚ุฑูŠุจุง ููŠ ุทุฑูŠู‚ุฉ ุฅู„ู‰ ุงู„ู„ูˆูƒูŠู…ูŠุง ูŠุนู†ูŠ ุฎู„ุงุต ุจุฏุฃุช ุชุฌู„ุจ
211
00:17:17,650 --> 00:17:22,450
in transformation ุงู„ู€ monocyte ุฃู‚ู„ ู…ู† ูˆุงุญุฏ Ringed cell
212
00:17:22,450 --> 00:17:27,110
plus ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ูˆู†ุจุฏุฃ ู†ุดูˆู our body in plus cell
213
00:17:27,110 --> 00:17:35,360
ูˆููŠ ุฒูŠุงุฏุฉ ููŠ ุงู„ granulocyte count ู„ู€ Granulocyte
214
00:17:35,360 --> 00:17:40,860
ูˆุงู„ู€ pro ูˆุทุจุนุง ุจุดูƒู„ ุฃุณุงุณูŠ Chronic Myelomonocytic
215
00:17:40,860 --> 00:17:44,880
leukemia ุงู„ุจู„ุงุณุชู‚ุงู„ ู…ู† ุฎู…ุณุฉ ุงู„ .. ููŠ ุงู„ peripheral
216
00:17:44,880 --> 00:17:49,860
blood ุฃู‚ู„ ู…ู† ุนุดุฑูŠู† ููŠ ุงู„ู€ bone marrow ูˆุฃูƒุซุฑ ู…ู† ูˆุงุญุฏ ู„ุฃู†
217
00:17:49,860 --> 00:17:54,940
ู‡ุฐุง ู‡ูˆ ุงู„ุนุงู…ู„ ุงู„ู„ูŠ ุจูŠุฎุตู‡ุง ูŠุนู†ูŠ ุฃูƒุซุฑ ู…ู† ุฃู„ู
218
00:17:54,940 --> 00:18:01,560
monocytes ููŠ ุงู„ peripheral blood ูˆุฃู‚ู„ ู…ู† 15 Ringed
219
00:18:01,560 --> 00:18:06,160
Sideroblast ูˆููŠ ุฒูŠุงุฏุฉ ู„ู€ promonocytes ู‡ุฐุง ุฌุฏูˆู„
220
00:18:06,160 --> 00:18:09,280
ุชู‚ุฑูŠุจุง ุจูˆุถุญ ู„ูŠ ุงู„ุฃู†ูˆุงุน ุงู„ู…ุฎุชู„ูุฉ ูˆุงู„ู„ูŠ ุฅู† ุดุงุก ุงู„ู„ู‡
221
00:18:09,280 --> 00:18:14,020
ู‡ู†ุฌูŠ ุฅู„ูŠู‡ุง ุฏุงุฆู…ุง ุจุงู„ุชูุตูŠู„ ูˆุงุญุฏ ูˆุฑุง ุงู„ุชุงู†ูŠุฉ ูˆุฃูˆู„
222
00:18:14,020 --> 00:18:17,500
ู‡ุฐู‡ ุงู„ุฃู†ูˆุงุน ุงู„ู„ูŠ ู‡ูˆ Refractory Anemia ู‚ู„ู†ุง ุจูŠุตูŠุฑ
223
00:18:17,500 --> 00:18:21,300
ููŠู‡ุง by definition dysplasia ู„ู€ erythroid series only
224
00:18:21,300 --> 00:18:25,400
clinically ููŠ ุฃู†ูŠู…ูŠุง which is refractory to
225
00:18:25,400 --> 00:18:29,590
treatment ุชุฏูŠู‡ุง ูƒู„ ุงู„ู…ู‚ูˆูŠุงุช ู…ุง ุชุณุชุฌูŠุจ ู„ู„ุนู„ุงุฌ ู…ูŠุฑูˆ
226
00:18:29,590 --> 00:18:32,790
blast ุฃู‚ู„ ู…ู† ูˆุงุญุฏ ููŠ ุงู„ู€ peripheral blood ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ููŠ
227
00:18:32,790 --> 00:18:37,190
ุงู„ู€ bone marrow ูˆู…ุงููŠุด sideroblast ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ุนุดุฑ ูˆู…ุงููŠุด
228
00:18:37,190 --> 00:18:42,970
our body ูˆูƒุงู†ูˆุง you have to exclude other
229
00:18:42,970 --> 00:18:50,610
etiological agents ุฅูŠุด ูŠุนู†ูŠุŸ ุฃูŠ ุฃุณุจุงุจ ุฃุฎุฑู‰ ุจุชุนู…ู„
230
00:18:50,610 --> 00:18:55,770
ู‡ุฐู‡ ุงู„ุตูˆุฑุฉ ู„ุงุฒู… ุชุณุชุซู†ูŠู‡ุง ู…ู†ู‡ุง drug or toxin
231
00:18:55,770 --> 00:18:59,650
exposure Viral Infection, Vitamin Deficiency,
232
00:19:00,110 --> 00:19:04,090
Congenital Disease ุงุณุชุซู†ุงุก ู‡ุฐู‡ ุงู„ุดุบู„ุงุช ุถุฏ ุงู„ู€
233
00:19:04,090 --> 00:19:09,830
Refractory Anemia ู‡ูŠ ุงู„ุชุดุฎูŠุต ุงู„ุฏู†ูŠุง ุชุฌู‡ูŠ ู…ู† ุฎู…ุณุฉ
234
00:19:09,830 --> 00:19:14,190
ู„ุนุดุฑ ุญุงู„ุงุช ููŠ ุนุดุฑุฉ ููŠ ุงู„ู…ูŠุฉ ู…ู† ุงู„ู€ MDS ูˆู‡ูŠ ุชุตูŠุจ
235
00:19:14,190 --> 00:19:18,230
ุงู„ุงุฎุชูŠุงุฑูŠุฉ morphologically ุจู†ุดูˆู anisocytosis poikilocytosis
236
00:19:18,230 --> 00:19:24,310
ููŠ ุงู„ peripheral smear ูˆููŠ dyserythropoiesis with
237
00:19:24,310 --> 00:19:28,650
nuclear abnormality ุจู†ุดูˆู ุฃุดู‡ุฑ ุญุงุฌุฉ megaloblastoid
238
00:19:28,650 --> 00:19:33,830
changes megaloblastoid ูƒุจูŠุฑุฉ blastoid ู…ู† blast
239
00:19:33,830 --> 00:19:40,390
ู…ุงุดูŠ ูŠุนู†ูŠ immature changes ูˆู‡ูŠ ุฃู‚ู„ ู…ู† 15% ringed
240
00:19:40,390 --> 00:19:46,850
sideroblast genetics 25% may have genetic abnormality
241
00:19:46,850 --> 00:19:50,190
ูˆู„ูŠู‡ ุงู„ diagnosis ู‚ุงู„ูˆุง ุจูŠุนูŠุด ุงู„ median survival
242
00:19:50,920 --> 00:19:57,460
time ุญูˆุงู„ูŠ 66 ุดู‡ุฑ ู„ูƒู† 6% ู…ู†ู‡ู… ุจูŠุฌู„ุจูˆุง ู„ู€ acute
243
00:19:57,460 --> 00:20:02,840
leukemia ุจูŠุชุทูˆุฑ ุงู„ู…ุฑุถ ุนู†ุฏู‡ู… to acute leukemia ูˆู‡ุฐุง
244
00:20:02,840 --> 00:20:08,100
ุงู„ peripheral smear ุฃูŠ anisocytosis poikilocytosis ุทุจุนุง
245
00:20:08,100 --> 00:20:10,920
ุงู„ู€ anisocytosis ุงุฎุชู„ุงู ุงู„ุญุฌูˆู… poikilocytosis
246
00:20:10,920 --> 00:20:15,840
ุงุฎุชู„ุงู ุงู„ุฃุดูƒุงู„ ูˆุชุฎูŠู„ูˆุง ุงู„ู€ bone marrow ุดุงูŠููŠู† ูƒูŠู
247
00:20:15,840 --> 00:20:21,900
ุงู„ุฎู„ุงูŠุง ุชุชูƒุณุฑ ุญุชู‰ ููŠ ุงู„ู€ bone marrow ูˆู‡ูŠ ุจุชูƒูˆู† ุฎู„ุงูŠุง
248
00:20:21,900 --> 00:20:26,240
ู…ุดูˆู‡ุฉ ู…ุนุธู… ุงู„ุฎู„ุงูŠุง ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ู‡ูŠ ุนุจุงุฑุฉ ุนู† ุฎู„ุงูŠุง
249
00:20:26,240 --> 00:20:32,280
ู…ุดูˆู‡ุฉ ูˆู‡ูŠ megaloblastoid changes ูƒุจูŠุฑุฉ ู„ู…ู†ุŸ
250
00:20:32,280 --> 00:20:41,440
ู„ุฎู„ุงูŠุง ุงู„ู€ RBCs megaloblastoid ุชูƒุจุฑ ูƒุชูŠุฑ ุงู„ู…ุฑุฉ
251
00:20:41,440 --> 00:20:43,820
ุงู„ุซุงู†ูŠุฉ ุงู„ู€ refractory ูŠุนู†ูŠ ู…ุง ู‡ูˆ ุงู„ู€ Ring sideroblast
252
00:20:43,820 --> 00:20:46,480
ูˆู‡ุฐุง ุจูŠุตูŠุฑ ููŠู‡ dysplasia
253
00:20:49,160 --> 00:20:52,060
Clinically, anemia is refractory to hematinic
254
00:20:52,060 --> 00:20:56,080
therapy ุฒูŠ ุงู„ุฃูˆู„ุงู†ูŠ ูˆู†ูุณ ุงู„ุญูƒุงูŠุฉ ุงู„ myeloblast ููŠ
255
00:20:56,080 --> 00:20:59,320
ุงู„ู€ peripheral blood ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ูˆููŠ ุงู„ู€ bone
256
00:20:59,320 --> 00:21:03,540
marrow ุฃู‚ู„ ู…ู† ูˆุงุญุฏ ูˆุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ููŠ ุงู„ู€ bone marrow
257
00:21:03,540 --> 00:21:07,760
ููŠ Ringed Sideroblast ูˆููŠ sideroblast ู„ูƒู† you have
258
00:21:07,760 --> 00:21:12,540
to exclude antituberculosis drug ูˆุงู„ู€ alcohol ูˆ
259
00:21:12,540 --> 00:21:16,220
ุงู„ู€ lead ุงู„ุฏู…ูˆู„ูˆุฌูŠ ู…ู† ุนุดุฑ ุฃูˆ ุงุซู†ุง ุนุดุฑ ููŠ ุงู„ู…ูŠุฉ ู…ู† ุงู„ู€ MDS
260
00:21:16,220 --> 00:21:19,700
ุญุงู„ุงุช ุงู„ู€ MDS ูˆุจูŠุตูŠุจ ุงู„ุงุฎุชูŠุงุฑูŠุฉ ูˆุงู„ู€ males ุฃูƒุซุฑ ู…ู†
261
00:21:19,700 --> 00:21:22,700
ุงู„ู€ females ูˆ morphologically ุจู†ุดูˆู pattern
262
00:21:22,700 --> 00:21:27,460
dimorphic ูŠุนู†ูŠ ุดูƒู„ูŠู† ูŠุนู†ูŠ ุงู„ุฎู„ุงูŠุง ู„ู‡ุง ุดูƒู„ูŠู† on
263
00:21:27,460 --> 00:21:32,740
peripheral smears ู…ุนุธู… ุงู„ู€ RBCs normochromic ู„ูƒู† ููŠ
264
00:21:32,740 --> 00:21:38,340
second population ูˆู‡ูˆ hypochromic ุทุจุนุง ููŠ this
265
00:21:38,340 --> 00:21:42,140
ูŠุนู†ูŠ abnormal erythropoiesis ููŠ nuclear
266
00:21:42,140 --> 00:21:46,460
abnormalities ูˆุจู†ุดูˆู ุงู„ megaloblastoid changes
267
00:21:48,130 --> 00:21:54,430
ู…ูุฑูˆุถ ูŠู‚ู„ ู…ู† 15% Ringed Sideroblast ุงู„ู€ Ringed Sideroblast
268
00:21:54,430 --> 00:21:58,130
ู‡ูŠ ุนุจุงุฑุฉ ุนู† erythroid ุงู„ู€ precursor cell ููŠู‡ุง ุฃูƒุซุฑ
269
00:21:58,130 --> 00:22:05,170
ู…ู† ุนุดุฑุฉ Siderotic granules ูˆู‡ุฐู‡ Siderotic granules
270
00:22:05,170 --> 00:22:12,730
in circling ุชู‚ุฑูŠุจุง ุซู„ุซ ุฃูˆ ุฃูƒุซุฑ ู…ู† ุซู„ุซ ุงู„ุฃู†ูˆุงุน if
271
00:22:12,730 --> 00:22:21,080
excess blast presence this dictates diagnosis ุญุชู‰
272
00:22:21,080 --> 00:22:27,740
ุจุงู„ุฑุบู… ู…ู† ุงู„ percentage of ringed sideroblast ู…ุงุดูŠ
273
00:22:27,740 --> 00:22:32,700
ุจุบุถ ุงู„ู†ุธุฑ ุนู† ูˆุฌูˆุฏ ุงู„ ringed sideroblast ุฅุฐุง ุดูู†ุง ุงู„
274
00:22:32,700 --> 00:22:37,360
blast ู…ูˆุฌูˆุฏุฉ ู‡ุฐุง ุนู„ู‰
275
00:22:37,360 --> 00:22:43,500
ุทูˆู„ ุจูŠุฎู„ู†ุง ู†ููƒุฑ ููŠ ุงุชุฌุงู‡ ุขุฎุฑ genetically
276
00:22:45,410 --> 00:22:48,710
ููŠ ูƒู„ูˆู†ุฉ ุฃูˆ ูƒุฑูˆู…ูˆุณูˆู… ุงู„ abnormality ุฃู‚ู„ ู…ู† 10% ู…ู†
277
00:22:48,710 --> 00:22:53,550
ุงู„ุญุงู„ุงุช develop such abnormality ูˆุจุงู„ุชุงู„ูŠ you have
278
00:22:53,550 --> 00:22:58,830
to reassess their diagnoses ุงู„ median survival
279
00:22:58,830 --> 00:23:07,010
time ุณุช ุณู†ูˆุงุช ูˆ 72 ุดู‡ุฑ ูˆ 1-2% ู…ู† ุงู„ุญุงู„ุงุช ุจูŠุฌู„ุจ ู„ู€
280
00:23:07,010 --> 00:23:13,170
acute leukemia ูˆู‡ูŠ dimorphic ุดุงูŠููŠู† ุงู„ุดูƒู„ูŠู†
281
00:23:13,760 --> 00:23:22,680
ุงู„ู„ูŠ ู…ูˆุฌูˆุฏูŠู† ู„ู„ู€ RBCs ูˆู‡ูŠ Ringed Cedroplast ูƒู…ุง
282
00:23:22,680 --> 00:23:27,860
ุชุดุงูŠููŠู† ู‡ูŠ Ringed Cedroplast ุฃูƒุซุฑ ู…ู† ุชู„ุช ุงู„ุฎู„ุงูŠุง is
283
00:23:27,860 --> 00:23:34,520
ringed by cedrotic body ูˆู‡ุฐุง ู‡ูŠ Ringed Cedroplast
284
00:23:36,170 --> 00:23:39,870
ู‡ูˆ ุงู„ู€ megaloblastoid ุงู„ุงุฎุชู„ุงูุงุช ุงู„ุชูŠ ู†ุดุงู‡ุฏู‡ุง ููŠ
285
00:23:39,870 --> 00:23:45,370
ุงู„ู€ RBC's ุชูƒุจุฑ ูˆ ู†ูŠูƒู„ูŠุงุณู‡ุง ุบูŠุฑ ุทุจูŠุนูŠุฉ ูˆ ูƒู„ ุดูŠุก
286
00:23:45,370 --> 00:23:52,250
ููŠู‡ุง ุบูŠุฑ ุทุจูŠุนูŠ ู†ูˆุน ุงู„ุชุงู„ุช reflector ูŠุนู†ูŠ ู…ุง with
287
00:23:52,250 --> 00:23:59,170
excessive blast ูŠุงู„ู‡ by definition ู‡ุฐุงููŠ ุจูŠูƒูˆู†
288
00:23:59,170 --> 00:24:03,750
ุฎู…ุณุฉ ู„ุชุณุนุฉ ุนุดุฑ ููŠ ุงู„ู…ุฆุฉ ู…ู† ุงู„ myeloplast present
289
00:24:03,750 --> 00:24:07,570
ููŠ ุงู„ู€ bone marrow ู‚ุณู…ูˆู‡ุง ู„ู†ูˆุนูŠู† ู‚ุงู„ูˆุง ุฅุฐุง ุงู„ู€ blast
290
00:24:07,570 --> 00:24:12,590
ู…ู† ุฎู…ุณุฉ ู„ุชุณุนุฉ ููŠ ุงู„ู…ุฆุฉ ููŠ ุงู„ู€ bone marrow ูˆุฃู‚ู„ ู…ู†
291
00:24:12,590 --> 00:24:15,890
ุฎู…ุณุฉ ููŠ ุงู„ู€ blood ุจูŠุณู…ูˆู‡ุง Refractory Anemia
292
00:24:15,890 --> 00:24:20,930
Blast I ูˆุฅุฐุง ุงู„ู€ blast ุฃู‚ู„ ู…ู† ุนุดุฑุฉ ู„ุชุณุนุฉ ุนุดุฑ ููŠ
293
00:24:20,930 --> 00:24:25,590
ุงู„ู…ุฆุฉ ููŠ ุงู„ู€ bone marrow ูˆููŠ ุฃูˆู„ root body ุจูŠุณู…ูˆู‡ุง
294
00:24:25,590 --> 00:24:32,510
Refractory Anemia Blast II ุงู„ุฏูŠู†ุงู„ูˆุฌูŠุง ุจุดูƒู„
295
00:24:32,510 --> 00:24:36,570
ุฃุฑุจุนูŠู† ููŠ ุงู„ู…ุฆุฉ ู…ู† ุญุงู„ุงุช ุงู„ู€ MDS ุจุชุฌูŠุจ ุงู„ุงุฎุชูŠุงุฑูŠุฉ ูˆ
296
00:24:36,570 --> 00:24:42,800
morphologically ููŠ Dysplasia ููŠ ูƒู„ ุฃู†ูˆุงุน ุงู„ุฎู„ุงูŠุง ููŠ
297
00:24:42,800 --> 00:24:49,380
ู†ุชุฑูˆููŠู„ ุฃุจู†ุฑู…ุงู„ุชูŠ ุงู„ุชูŠ ู‚ุฏ ุชุดู…ู„ Hypogranulation
298
00:24:49,380 --> 00:24:55,180
Hypersegmentation ุณูˆุฏูˆ ุจุงู„ูƒุฑู‡ูˆุช Anomaly ุงู„ู„ูŠ ู‡ูˆ
299
00:24:55,180 --> 00:24:59,740
ุนุจุงุฑุฉ ุนู† Hypersegmentation ู…ุน ุจุงุฑ ุจุงู„ู€ shape
300
00:24:59,740 --> 00:25:03,620
ู„ู„ู†ูƒู„ูŠุงุณ
301
00:25:03,620 --> 00:25:08,050
ุจุนุฏูŠู† ุณูˆุฏูˆ ุชุดูŠุฏูŠุง ูƒูŠุฌุงุดูŠ GranulesููŠ abnormality
302
00:25:08,050 --> 00:25:11,130
filigranous of neutrophil ู…ูŠุฌุง ูƒุงุฑูŠูˆุณุงูŠุช
303
00:25:11,130 --> 00:25:14,970
abnormality ู…ู…ูƒู† ู†ุดูˆู hybolobulation ูˆู…ู…ูƒู† ู†ุดูˆู
304
00:25:14,970 --> 00:25:21,770
micro ู…ูŠุฌุง ูƒุงุฑูŠูˆุณุงูŠุช ููŠ ู‡ุฐุง ุงู„ู†ูˆุน ุงู„ู€ morphology
305
00:25:21,770 --> 00:25:26,210
erythroid glucosal abnormality ู…ู…ูƒู† ู†ุดูˆู ููŠู‡ุง
306
00:25:26,210 --> 00:25:29,270
abnormal lobulation ู…ูŠุฌุง ุฃุฑูˆุจู„ุงุณุชูˆูŠุฏ and
307
00:25:29,270 --> 00:25:35,390
multinucleation ูˆุฅุฐุง ูƒุงู† ุงู„ู€ myeloblast ู…ู…ูƒู†
308
00:25:35,390 --> 00:25:40,870
ุชูƒูˆู† ู…ู† 0 ู„ู€ 19 ููŠ ุงู„ู€ blood ุฃูˆ ู…ู† ุฎู…ุณุฉ ู„ุชุณุนุฉ ุนุดุฑ ููŠ
309
00:25:40,870 --> 00:25:46,530
ุงู„ู€ bone marrow ุบุงู„ุจุง ุงู„ู€ bone marrow is hypercellular ูู‚ุท
310
00:25:46,530 --> 00:25:50,110
ุนุดุฑ ู„ุฎู…ุณุฉ ุนุดุฑ ููŠ ุงู„ู…ุฆุฉ hypercellular ูˆูู‰ abnormal
311
00:25:50,110 --> 00:25:55,410
localization of immature ุจูƒุงุณุฑ ุงู„ู„ู‰ ู‡ูˆ abnormal
312
00:25:55,410 --> 00:26:02,780
localization of immature precursor cell may be
313
00:26:02,780 --> 00:26:07,500
present ุงู„ู…ู‡ู… ููŠ ุฃู† ุฎู„ุงูŠุง ุจูŠูƒูˆู† ุนุตุฑุชู‡ุง ุณู†ุฉ ุณุชุฉ ุนุดุฑ
314
00:26:07,500 --> 00:26:14,640
ุชู‚ุตุฏู‰ ุซู„ุงุซุฉ ุนุดุฑ ุซู„ุงุซุฉ ูˆ ุซู„ุงุซูŠู† ู…ูŠูˆ ุณุจุนุฉ ุนุดุฑ ูˆ ุงู„ู†ูˆุน
315
00:26:14,640 --> 00:26:20,480
ุงู„ูˆุญูŠุฏ ู…ู† ุงู„ู€ ู…ู† ุงู„ู€ myelodysplastic syndrome which
316
00:26:20,480 --> 00:26:27,580
have relevant phenotype category
317
00:26:27,580 --> 00:26:33,440
ูŠุนู†ูŠ Genetic ุทุจุนุง ุณุฌู„ุช ุญุงู„ุงุช ูƒุซูŠุฑุฉ ู…ู†ู‡ุง ูƒุฑู…ูˆุฒูˆู…ุฉ
318
00:26:33,440 --> 00:26:36,820
ู„ุฃุจู†ูˆุฑู…ุงู„ูŠุชูŠ ู…ู† ุซู„ุงุซูŠู† ู„ุฎู…ุณูŠู† ููŠ ุงู„ู…ุฆุฉ ู…ู† ุงู„ุญุงู„ุงุช
319
00:26:36,820 --> 00:26:42,540
Prognosis median survival time ู„ู€ type one ุทุจุนุง ุซู„ุงุซุฉ ุนุดุฑ
320
00:26:42,540 --> 00:26:47,480
ุดู‡ุฑ ูˆ type two ุนุดุฑ ุฃุดู‡ุฑ ูˆุฎู…ุณุฉ ูˆุนุดุฑูŠู† ููŠ ุงู„ู…ุฆุฉ ู…ู†
321
00:26:47,480 --> 00:26:50,520
ุญุงู„ุงุช type one ุชุฌู„ุจ ู„ุงู„ู„ูˆูƒูŠู…ูŠุง ุจูŠู†ู…ุง ุซู„ุงุซุฉ ูˆ ุซู„ุงุซูŠู†
322
00:26:50,520 --> 00:26:56,020
ููŠ ุงู„ู…ุฆุฉ ู…ู† ุงู„ู„ูŠ ู‡ูˆ type two ุจุฌู„ุจ ู„ุงู„ู„ูˆูƒูŠู…ูŠุง ูˆู‡ูŠ
323
00:26:56,020 --> 00:27:00,690
ุงู„ู€ hypercellular bone marrow ู…ู„ูŠุงู† ุฎู„ุงูŠุง ูˆู‡ูŠ ุงู„ู€
324
00:27:00,690 --> 00:27:08,170
Blast and hypogranulation ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ูˆู‡ูŠ
325
00:27:08,170 --> 00:27:13,210
ุงู„ู€ megaloblastoid ุงู„ู„ูŠ ู…ู„ุงุญุธู‡ุง with our sorry
326
00:27:13,210 --> 00:27:16,530
myeloblast with our root body ู„ุฃู†ู‡ ุจู†ุชุญูƒูŠ ุนู„ู‰
327
00:27:16,530 --> 00:27:21,390
blast the excess blast ูˆู‡ูŠ ููŠู‡ vacuoles ููŠ ุงู„ู€
328
00:27:21,390 --> 00:27:25,830
cytoplasm ูˆู‡ูŠ ูƒู„ ุงู„ู€ abnormality ุจุชุงุนุฉ ุงู„ู€
329
00:27:25,830 --> 00:27:31,980
neutrophil ุณูˆุงุก ูƒุงู†ุช Shiryak-Higashi ุจุฃู†ูˆุงุน ู…ุฎุชู„ูุฉ
330
00:27:31,980 --> 00:27:35,300
ุขุฎุฑ ู‡ุฐู‡ ุงู„ุฃู†ูˆุงุน ุงู„ู„ูŠ ู‡ูˆ Refractory Anemia with
331
00:27:35,300 --> 00:27:40,660
excess blast in transformation ุจุดูƒู„
332
00:27:40,660 --> 00:27:47,960
21 ู„ู€ 30% ู…ู† ุญุงู„ุงุช ุงู„ู„ูŠ ู‡ูˆ sorry ููŠ 21 ู„ู€ 30% ู…ู† ุงู„ู€
333
00:27:47,960 --> 00:27:52,620
blast ููŠ ุงู„ู€ bone marrow ูˆ ุฃูƒุซุฑ ู…ู† 5% blast ููŠ ุงู„ู€
334
00:27:52,620 --> 00:27:56,520
peripheral blood ูˆ ููŠ excessive number ูˆ mono size
335
00:27:57,540 --> 00:28:02,040
ูˆู‡ูŠ normal hyper or hypercellular bone marrow
336
00:28:02,040 --> 00:28:05,960
ูˆุจูŠุดูƒู„ 25% ู…ู† ุงู„ุญุงู„ุงุช
337
00:28:11,280 --> 00:28:16,020
ุงู„ู„ูŠ ู‡ูˆ ุจูŠูƒูˆู† ููŠู‡ ุฎู…ุณุฉ ู„ุนุดุฑูŠู† ููŠ ุงู„ู…ุฆุฉ blast ููŠ ุงู„ู€
338
00:28:16,020 --> 00:28:19,880
bone marrow ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ููŠ ุงู„ู…ุฆุฉ ููŠ ุงู„ู€ blood stream ููŠ
339
00:28:19,880 --> 00:28:24,960
cytopenia ููŠ at least in at least two line ูˆููŠ
340
00:28:24,960 --> 00:28:28,260
normal or hypercellular bone marrow ุจุดูƒู„ ุฎู…ุณุฉ
341
00:28:28,260 --> 00:28:35,480
ูˆุฎู…ุณุฉ ุนุดุฑ ู„ุนุดุฑูŠู† ููŠ ุงู„ู…ุฆุฉ ู…ู† ุญุงู„ุงุช ุงู„ู€ MDS IUCMML
342
00:28:35,480 --> 00:28:40,370
splenomegaly ู…ุงูŠูƒูŠู„ูˆุจ popular skin infiltration
343
00:28:40,370 --> 00:28:46,250
ุจูŠูƒูˆู† ููŠ monocytic plural ุฃูˆ pericardial effusion
344
00:28:46,250 --> 00:28:52,210
ูˆููŠ ุฌูˆู†ุงุน ุงู„ู€ myelomonocytic leukemia ู…ุฑุงุช ุจูŠูƒูˆู† ููŠ
345
00:28:52,210 --> 00:28:57,990
myeloproliferative dysplasia ุฃูˆ myelodysplastic
346
00:28:57,990 --> 00:29:02,070
syndrome pallor, bleeding, hepatosplenomegaly
347
00:29:02,070 --> 00:29:03,930
ูˆ skin involvement
348
00:29:06,850 --> 00:29:13,910
ู‡ุฐุง ู…ุง ูŠุชุนู„ู‚ ุจุงู„ุฃู†ูˆุงุน ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ myelodysplasia
349
00:29:13,910 --> 00:29:19,070
according to FAB classification ู„ูƒู† WHO ุฅุฌุช ุนู…ู„ุช
350
00:29:19,070 --> 00:29:24,070
classification ุฌุฏูŠุฏ ู„ู„ู€ myelodysplastic syndrome
351
00:29:24,070 --> 00:29:29,050
ูˆู‚ุงู„ุช ู„ุฃ ุงุญู†ุง ุงู„ุฃู†ูˆุงุน ุจุฏู†ุง ู†ู‚ุณู…ู‡ุง ุฅู„ู‰ ุซู…ุงู† ุฃู†ูˆุงุน
352
00:29:29,050 --> 00:29:34,090
ู…ุด ุฎู…ุณ ุฃู†ูˆุงุน ุฒูŠ ู…ุง ู‚ุณู…ูˆู‡ุง ููŠ ุงู„ูุงุจ ุฃูŠุด ุงู„ุฃู†ูˆุงุนุŸ ู‡ูˆ
353
00:29:34,090 --> 00:29:37,470
Refractory Anemia ูˆ Refractory Anemia with Ringed
354
00:29:37,470 --> 00:29:41,010
Cedroblast ุซู… Refractory Cytopenia with
355
00:29:41,010 --> 00:29:45,530
Multilineage Dysplasia ูˆ Refractory Cytopenia with
356
00:29:45,530 --> 00:29:49,770
Multilineage Dysplasia and Ringed Cedroblast ุซู…
357
00:29:49,770 --> 00:29:53,930
Refractory Anemia with Excessive Blast 1 ูˆ 2 ุซู…
358
00:29:53,930 --> 00:29:58,630
Myelodysplastic Syndrome Unclassified ู…ุง ู„ู‡ ุฃูŠุฉ ุซู…
359
00:29:58,630 --> 00:30:09,430
Associated with Isolated deletion of 5q. ู‡ูˆ ูŠุฌุจ ุฃู†
360
00:30:09,430 --> 00:30:12,110
ู†ู‚ูˆู„ ุฅู† ุงู„ู€ Refractory Anemia ู…ุตุญูˆุจุฉ ุนุงุฏุฉ
361
00:30:12,110 --> 00:30:15,730
ุจุงู„ุฃู†ูŠู…ูŠุง ูˆููŠ Erythroid dysplasia onlyุŒ Ringed
362
00:30:15,730 --> 00:30:19,330
Cedroblast ููŠ ุฃู†ูŠู…ูŠุง ูˆููŠ ุฃูƒุซุฑ ู…ู† 15% Ringed
363
00:30:19,330 --> 00:30:22,450
CedroblastุŒ Refractory Cytopenia ูˆ Multilinear
364
00:30:22,450 --> 00:30:28,060
Dysplasia ููŠ ุฃูŠ Bad CytopeniaุŒ ุงุซู†ูŠู†. ูˆุงู„ู€
365
00:30:28,060 --> 00:30:30,740
Refractory Cytopenia with Multilinear Dysplasia
366
00:30:30,740 --> 00:30:34,060
with Ringed Cedroblast ุจูŠูƒูˆู† ููŠู‡ ุฃูƒุซุฑ ู…ู† 15%
367
00:30:34,060 --> 00:30:40,280
Ringed Cedroblast ูˆ Excess Blast 1 ุจูŠูƒูˆู† ู„ู€ Blast
368
00:30:40,280 --> 00:30:44,260
ุฃู‚ู„ ู…ู† 5 ููŠ ุงู„ู€ blood ูˆุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ู„ุชุณุนุฉ ููŠ ุงู„ู€ bone
369
00:30:44,260 --> 00:30:48,500
marrow ูˆููŠ ุงุซู†ูŠู† ุจูŠูƒูˆู† ู…ู† ุฎู…ุณุฉ ู„ุชุณุนุฉ ุนุดุฑ ููŠ ุงู„ู€
370
00:30:48,500 --> 00:30:51,540
peripheral blood ูˆู…ู† ุนุดุฑ ู„ุชุณุนุฉ ุนุดุฑ ููŠ ุงู„ู€ bone
371
00:30:51,540 --> 00:30:56,220
marrow ุงู„ู€ unclassified ุจูŠูƒูˆู† ููŠู‡ cytopenia ููŠ ุงู„ู€
372
00:30:56,220 --> 00:31:01,320
blood ูˆููŠ myeloid ุฃูˆ megakaryocyte dysplasia ุงู„ู€ 5q
373
00:31:01,320 --> 00:31:07,820
type ุจูŠูƒูˆู† ููŠู‡ ุฃู†ูŠู…ูŠุง ูˆ ... ูˆ ุจูŠูƒูˆู†ุด
374
00:31:10,480 --> 00:31:16,300
ุฃู†ูŠู…ูŠุง ูˆู„ุง ููŠ ุฒูŠุงุฏุฉ ููŠ ุงู„ู€ Platelet ู„ูƒู† ุจูŠูƒูˆู† ููŠ
375
00:31:16,300 --> 00:31:21,720
ู…ูŠุฌุง ูƒุงุฑูŠูˆุณูŠุชูƒ
376
00:31:21,720 --> 00:31:28,680
Cell with high poly related nuclei ุฃูˆ ุฃู‚ู„ ู…ู† 5%
377
00:31:28,680 --> 00:31:34,210
ุจุงู„ุญุตุฉ ุดูˆ ุงู„ู„ูŠ ุจูŠู‚ุงุจู„ ุฅุดูŠ ููŠ WHO ู…ุน ุงู„ุฑูุงู‚ุŸ ู‡ูˆ ุงู„ู€
378
00:31:34,210 --> 00:31:36,790
Refractory Anemia ุงู„ู„ูŠ ุจูŠู‚ุงุจู„ู‡ุง ููŠ ุงู„ู€ WHO
379
00:31:36,790 --> 00:31:39,690
Refractory Anemia with Refractory Cytopenia with
380
00:31:39,690 --> 00:31:44,410
Multilineage Dysplasia 5q Syndrome Ring Syndrome
381
00:31:44,410 --> 00:31:53,650
Blast ุจุฑุถู‡ ุจูŠู‚ุงุจู„ู‡ุง ุงู„ุฑุฃุณ ูˆ ุฑุฃุณ RCMDRS ุฃูˆ ุงู„ุฑุฃุณ ุงู„ู€
382
00:31:53,650 --> 00:31:56,910
Excessive Blast 1 ูˆ 2 Transformation with
383
00:31:56,910 --> 00:32:02,060
Multilineage Dysplasia ูˆู‡ูŠ CML ูˆู‡ูˆ myelodysplastic
384
00:32:02,060 --> 00:32:06,880
myeloproliferative disease Prognostic group ุญุชู‰
385
00:32:06,880 --> 00:32:11,700
ุชูˆุฌู‡ ู„ู€ two prognostic group ุจู†ุงุก ุนู„ู‰ survival and
386
00:32:11,700 --> 00:32:17,160
evolution to acute leukemia ุชุฌู„ุจ ู„ู€ acute leukemia
387
00:32:17,160 --> 00:32:21,660
ูุฌุงู„ู‡ ุงู„ุฌุฏ group ุงู„ู†ุงุณ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ุนู†ุฏู‡ู… refractory
388
00:32:21,660 --> 00:32:25,040
anemia ุฃูˆ refractory anemia with ring cedroblast
389
00:32:25,040 --> 00:32:29,370
ุฃูˆ FAQ ุจูŠู†ู…ุง ุงู„ู€ Body Group ู‡ูŠ ุงู„ู€ Refractory
390
00:32:29,370 --> 00:32:32,010
Anemia ูˆ Excessive Blast ูˆ Excessive Blast in
391
00:32:32,010 --> 00:32:37,490
Transformation ูˆ CMML ูˆู‡ูŠ ุทุจุนุง ุงู„ู†ูˆุน ุงู„ุชุงู„ุช ุงู„ู„ูŠ ู‡ูˆ
392
00:32:37,490 --> 00:32:43,070
ุงู„ู€ Unclassified ู…ู…ูƒู† ูŠูƒูˆู† ููŠ group one ูˆู„ุง group
393
00:32:43,070 --> 00:32:46,450
two ุนู†ุฏู‡
394
00:32:46,450 --> 00:32:51,750
Prognostic Scoring System ูŠุนู†ูŠ ู‚ุทูˆุง Scores ู„ูƒู„
395
00:32:51,750 --> 00:32:56,750
ู†ู‚ุทุฉ ู…ู† ุงู„ู…ู‚ุงุช ูˆุจู†ุงุก ุนู„ู‰ ุนุฏุฏ ุงู„ู€ Scores ุญุฏุฏูˆุง
396
00:32:56,750 --> 00:33:03,430
ุงู„ู€ prognosis ูุฌุฃุฉ ุงู„ู€ IPSS ุจูŠุนุชู…ุฏ ุนู„ู‰ percentage of
397
00:33:03,430 --> 00:33:08,450
blast ุนู„ู‰ ุฅุฐุง ููŠ ูƒุฑู…ูˆุฒูˆู…ุฉ abnormality ูˆู„ุง ู„ุฃ ูˆู‚ุฏุงุด
398
00:33:08,450 --> 00:33:13,710
ุงู„ู…ุฑูŠุถ ุนู†ุฏู‡ blood count ูˆู‡ุฏูˆู„ุฉ ุจู†ุญุทูˆุง score ุฒูŠ ู…ุง
399
00:33:13,710 --> 00:33:17,570
ู‚ู„ุชู„ูƒูˆุง ูƒู„ ู…ุง ู‚ู„ ุงู„ู€ score ูƒู„ ู…ุง ูƒุงู† ุฌูŠุฏ ุงู„ู€ prognosis
400
00:33:18,610 --> 00:33:23,590
ูุงูŠู„ ุจู„ุงุณุช ูŠูˆู… ูŠูƒูˆู† ุฃู‚ู„ ู…ู† ุฎู…ุณุฉ ุจู†ุนุทู‰ ุตูุฑ ู„ูƒู† ุตุงุฑ
401
00:33:23,590 --> 00:33:28,170
ุฎู…ุณุฉ ู„ุนุดุฑุฉ ุจุณุจุจ ุจูŠุงุฎุฏ ู†ุต ุฅุฐุง ูƒุงู† ุฃูƒุซุฑ ู…ู† ู‡ูŠูƒ ุจูŠุงุฎุฏ
402
00:33:28,170 --> 00:33:32,570
ูˆุงุญุฏ ู…ู† ุฃุญุฏ ุนุดุฑ ู„ุนุดุฑูŠู† ูˆุงุญุฏ ูˆู†ุตู ูˆู‡ูƒุฐุง ูƒุงุฑูŠูˆ ุชุงูŠุจ
403
00:33:32,570 --> 00:33:37,490
ุฅุฐุง positive ูˆู„ุง ู„ุฃ the opinion ู…ุงุดูŠ ุฅุฐุง ู…ู† ุตูุฑ
404
00:33:37,490 --> 00:33:42,870
ู„ูˆุงุญุฏ ุตูุฑ ุฅุฐุง ู…ู† ุงุซู†ูŠู† ู„ุซู„ุงุซุฉ ู†ุต ูˆู‡ูƒุฐุง ุชุฌู…ุน ู‡ุฐู‡
405
00:33:42,870 --> 00:33:50,100
ุงู„ุฃุฑู‚ุงู… ูˆูƒู„ ู…ุง ู‚ู„ ุงู„ุฑู‚ู… ูƒู„ ู…ุง ูƒุงู† prognosis good
406
00:33:50,100 --> 00:33:55,080
differential diagnosis several common diagnostic
407
00:33:55,080 --> 00:34:02,320
considerations given these findings ุทุจุนุง ุจุฏูƒ ุชุนู…ู„
408
00:34:02,320 --> 00:34:06,760
ุชุณุชุซู†ูŠ ุนุดุงู† ุชุดุฎุต ุงู„ู€ myelodysplasia ุชุดุฎุต ุชุณุชุซู†ูŠ
409
00:34:06,760 --> 00:34:10,920
ุงู„ุญุงู„ุงุช ุงู„ู‚ุงุชู„ุฉ ู†ุดูˆู ุฃุณุจุงุจ ุงู„ู€ Bone Marrow Failure
410
00:34:10,920 --> 00:34:15,020
ุงู„ู€ Diabetic ุฃูˆ ุงู„ู€ Drug Induced ูˆู†ุดูŠู„ู‡ุง ู†ุดูˆู ุฅุฐุง
411
00:34:15,020 --> 00:34:20,260
ููŠ Hypersplenism ูˆู„ุง ู„ุง ุซู… ุฅุฐุง ููŠ Vitamin B12 ูˆ
412
00:34:20,260 --> 00:34:25,500
Folic Acid Deficiency ูˆุญุงู„ุฉ ุงู„ู€ PNH ู…ู…ูƒู† ูŠูƒูˆู†
413
00:34:25,500 --> 00:34:32,120
ุนู†ุฏู‡ุง Similar Bone Marrow Finding ู…ุน ุงู„ู€ MDS ุทูŠุจ
414
00:34:32,120 --> 00:34:37,250
ูƒูŠู ู†ุนู…ู„ ุงู„ู€ Differentiation ุจูŠู† ุงู„ู€ Acute Non ุงู„ู€
415
00:34:37,250 --> 00:34:39,570
Lymphoblastic Leukemia ุฃูˆ ุงู„ู€ Myelodysplasia
416
00:34:39,570 --> 00:34:50,050
ุจุจุณุงุทุฉ ู†ุนู…ู„ ุงู„ู‚ุงุทุน ู…ู† ุฌู‡ุฉ ู†ุฌูŠุจ ู†ุนู…ู„
417
00:34:50,050 --> 00:34:58,310
ุจุฑูุฑุฉ blood ูˆู†ุดูˆู
418
00:34:58,310 --> 00:35:06,150
ู†ุณุจุฉ ุงู„ู€ Nucleated Cell ู†ุณุจุฉ ุงู„ู€ RBCs ุจุงู„ู†ุณุจุฉ ู„ู€
419
00:35:06,150 --> 00:35:11,870
Nucleated Cell ุทุจุนุง
420
00:35:11,870 --> 00:35:14,770
ุงู„ู€ ... ุนููˆุง ุงุญู†ุง ุจู†ุนู…ู„ ... ู†ุงุฎุฐ bone marrow ูˆููŠ ู‡ุฐู‡
421
00:35:14,770 --> 00:35:17,690
ุงู„ู€ bone marrow ู‡ูŠ ุงู„ู„ูŠ ุจุชุญุฏุฏ ู†ุงุฎุฏ bone marrow ูˆ
422
00:35:17,690 --> 00:35:21,430
ุจู†ุชุทู„ุน ุนู„ูŠู‡ ุจู†ุดูˆู ู†ุณุจุฉ ุงู„ู€ RBCs ุจุงู„ู†ุณุจุฉ ู„ู„ู€ Total
423
00:35:21,430 --> 00:35:28,370
Nucleated Cell ูุฅุฐุง ูƒุงู† ุงู„ู€ RBCs .. Nucleated RBCs
424
00:35:28,370 --> 00:35:33,040
ุฃูƒุซุฑ ู…ู† 50% ุจู†ุฏูˆุฑุŒ ุจู†ุดูˆู ุฌุฏู‘ูŠุด ููŠู‡ุง Blast ูˆู„ุง ุฅุฐุง ุงู„ู€
425
00:35:33,040 --> 00:35:38,400
BLAST ุฃูƒุซุฑ ู…ู† 30% ุจูŠุนู†ูŠุชู‡ ู„ูˆูƒูŠู…ูŠุง ูˆู…ู† ู†ูˆุน M6 ูˆุฅุฐุง
426
00:35:38,400 --> 00:35:43,120
ูƒุงู† ุงู„ู€ BLAST ุฃู‚ู„ ู…ู† 30% ุจูŠุนู†ูŠุชู‡ MDS ู„ู„ุญุงู„ุฉ
427
00:35:43,120 --> 00:35:49,840
ุงู„ุชุงู†ูŠุฉุŒ ู†ุดูˆู ู†ุณุจุฉ ุงู„ู€ Nucleated RBCs ุจุงู„ู†ุณุจุฉ ู„ู„ู€
428
00:35:49,840 --> 00:35:53,340
Nucleated Cell ุฅุฐุง ุฃู‚ู„ ู…ู† 50%ุŒ ู†ุฏูˆุฑ ุนู„ู‰ ุฌุฏู‘ูŠุด ููŠู‡ุง
429
00:35:53,340 --> 00:35:57,960
BLAST ูˆู„ุง ุฅุฐุง ุงู„ู€ BLAST ุฃูƒุซุฑ ู…ู† 30% ุจูŠุนู†ูŠุชู‡
430
00:35:57,960 --> 00:36:03,950
ู„ูˆูƒูŠู…ูŠุง ู„ู†ูˆุน ุขุฎุฑ ู…ู† ุงู„ู„ูˆูƒูŠู…ูŠุง ุบูŠุฑ M6ูˆุฅุฐุง ูƒุงู† ุงู„ู€
431
00:36:03,950 --> 00:36:09,650
BLAST ุฃู‚ู„ ู…ู† 30% ูู‡ูŠ MDS ูˆุจู‡ูŠูƒ ุจู†ูุฑู‚ ู…ุง ุจูŠู† ุงู„ู€
432
00:36:09,650 --> 00:36:12,790
Acute Non-Lymphoblastic Leukemia ูˆ ุงู„ู€ MDS
433
00:36:12,790 --> 00:36:20,370
Pathophysiology ุฃู‡ู… ุญุงุฌุฉ ุฃู†ู‡ ู†ุฏูˆุฑ ุนู„ู‰ .. ู†ุนุฑู ุฅูŠุด
434
00:36:20,370 --> 00:36:23,330
ุงู„ุณุจุจ ูุงู„ู€ Initial Hemopoietic Stem Cell Injury ู‡ูˆ
435
00:36:23,330 --> 00:36:28,290
ุงู„ุณุจุจ ูˆุทุจุนุง ู‡ุฐู‡ ู…ู…ูƒู† ุชูƒูˆู† due to cytotoxic
436
00:36:28,290 --> 00:36:33,740
chemotherapyุŒ radiationุŒ viralูˆ chemical exposure
437
00:36:33,740 --> 00:36:38,080
or genetic predisposition ุงู„ูƒุฑูˆู†ูŠุฉ ุงู„ู…ูŠูˆุชูŠุดู† ุงู„ู„ูŠ
438
00:36:38,080 --> 00:36:45,620
ุจุชูƒูˆู‘ู† over the bone marrow ุทุจุนุง ู‡ูˆ ุงู„ู„ูŠ ุจูŠุดูƒู„ ุงู„
439
00:36:45,620 --> 00:36:50,260
substance ุงู„ู€ healthy stem cell ูŠุนู†ูŠ ู‡ูˆ ุงู„ู„ูŠ ุจูŠุนูŠู‚
440
00:36:50,260 --> 00:36:56,810
ุงู„ู„ูŠ ู‡ูˆ ู†ุดุงุท ุงู„ู€ stem cellุจุงู„ู†ุณุจุฉ ู„ู„ุจุฑููŠุฑุงู„ ุจู„ุฏ
441
00:36:56,810 --> 00:37:05,070
ุงู„ู€ peripheral ุงู„ู€ peripheral
442
00:37:05,070 --> 00:37:06,710
ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral
443
00:37:06,710 --> 00:37:07,550
ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral
444
00:37:07,550 --> 00:37:07,650
ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral
445
00:37:07,650 --> 00:37:11,410
ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral
446
00:37:11,410 --> 00:37:15,950
ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral ุงู„ู€ peripheral
447
00:37:15,950 --> 00:37:20,990
ุงู„ู€ peripheral ุจุฑุถู‡ ุจู†ุนู…ู„ cpc ูˆ blood film ูˆ ุจู†ุดูˆู ุฌุฏู‘ุงุด
448
00:37:20,990 --> 00:37:24,370
ููŠู‡ premature RBC ููŠู‡ ุนู†ูŠู†ูŠุง ููŠู‡ macrovalocytosis
449
00:37:24,370 --> 00:37:27,750
ุจูŠุณุจุณู‡ ููŠ ุงู„ู€ stabling ูˆ ู‡ูƒุฐุง ูƒู„ ุงู„ู€ abnormality
450
00:37:27,750 --> 00:37:31,470
ุงู„ู€ erythro dysplasia ุชุดูˆู‡ุงุช ุงู„ู€ white blood cells ุจุฑุถู‡
451
00:37:31,470 --> 00:37:36,390
ุจู†ุดูˆูู‡ุง ูˆ thrombo dysplasia ุฃูŠุถุง ุจุชุฏูˆุฑ ุนู„ู‰
452
00:37:36,390 --> 00:37:39,530
thrombocytopenia ูˆ ุฅุฐุง ูƒุงู† ููŠู‡ large or tertiary
453
00:37:39,530 --> 00:37:43,340
platelet ู‡ุฐุง ุงู„ูƒู„ุงู… ูƒู„ู‡ ููŠ ุงู„ู€ peripheral blood ููŠ
454
00:37:43,340 --> 00:37:44,920
ุงู„ู€ bone marrow ู†ุนู…ู„ ู†ูุณ ุงู„ุญูƒุงูŠุฉ
455
00:37:44,920 --> 00:37:46,880
erythrodysplasia, leukodysplasia, and
456
00:37:46,880 --> 00:37:51,640
thrombodysplasia ูˆู‡ุฐุง ู‡ูˆ ุงู„ุฌุฏูˆู„ ุงู„ุฐูŠ ูŠูุฑู‚ ู…ุง ุจูŠู†
457
00:37:51,640 --> 00:37:56,700
ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ peripheral blood ูˆ ุงู„ู€ bone marrow ููŠ
458
00:37:56,700 --> 00:37:59,700
ุงู„ู€ myelodysplastic syndrome morphological
459
00:37:59,700 --> 00:38:08,080
abnormality of ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ peripheral blood and bone
460
00:38:08,080 --> 00:38:12,130
marrowููŠ myelodysplastic syndrome ูˆุทุจุนุง ุจูŠู† ุฃู†ูˆุงุน
461
00:38:12,130 --> 00:38:14,670
ู…ุฎุชู„ูุฉ ู…ู† ุงู„ุฎู„ุงูŠุง ุงู„ู„ูŠ ู‡ูŠ ุงู„ู€ erythroid ูˆู…ูŠู„ูŠูˆูŠุฏ ูˆู…ูŠูƒุง
462
00:38:14,670 --> 00:38:18,410
ูƒุงุฑูŠูˆุณูŠุช ูˆ ู‡ุฐุง ุงู„ุฌุฏูˆู„ ู…ุด ู„ู„ุญูุธ ู„ูƒู† ุถุฑูˆุฑูŠ ุชุนุฑููˆุง
463
00:38:18,410 --> 00:38:23,590
ุฃู†ู‡ ููŠู‡ ุชุดูˆู‡ุงุช ูˆุฃู†ูˆุงุน ู‡ุฐู‡ ุงู„ุชุดูˆู‡ุงุช survival time
464
00:38:23,590 --> 00:38:28,010
ุฌุงู„ู‡ refractory anemia ุจุนูŠุด ู…ู† ุณู†ุชูŠู† ู„ุฎู…ุณ ุณู†ูˆุงุช
465
00:38:28,010 --> 00:38:31,230
with ring syndrome blast ุฒูŠ ุงู„ู€ refractory anemia
466
00:38:31,230 --> 00:38:36,080
with excessive blast ุญูˆุงู„ูŠ ุนุดุฑ ุดู‡ูˆุฏ ูˆู‡ูˆ ู†ู…ุฑู‡ ุงุซู†ูŠู†
467
00:38:36,080 --> 00:38:41,580
ูˆ with excess blast in transformation ุงู„ู€ survival
468
00:38:41,580 --> 00:38:48,760
time is six month or less ูˆ ุทุจุนุง ู‡ุฐู‡ ุงู„ู€ median
469
00:38:48,760 --> 00:38:51,520
survival time ู„ู„ู…ูŠู„ูˆุฏุณุจู„ุงุณุชูŠูƒุณ ุณู†ุฏุฑู…ุง ุฒูŠ ู…ุง ุฃู†ุชู…
470
00:38:51,520 --> 00:38:52,500
ุดุงูŠููŠู† ุฏู‡ ู‡ูŠ
471
00:38:56,110 --> 00:39:00,750
ุงู„ู†ุณุจุฉ ู„ุนุฏุฏ ุงู„ุฃุดู‡ุฑ Treatment ุจูŠุนุทูˆู‡ ูƒูŠุจูˆ ุซูŠุฑุงุจูŠ ูˆ
472
00:39:00,750 --> 00:39:04,630
ุจูŠุนุทูˆู‡ supportive therapy ุฒูŠ ุงู„ู€ white cell PCR ุจูŠุดูŠู„ูˆุง
473
00:39:04,630 --> 00:39:11,350
platelet transfusion ูˆ ููŠ ุงู„ุญุงู„ุงุช ุงู„ุตุบูŠุฑุฉ ุงู„ุดุจุงุจ
474
00:39:11,350 --> 00:39:16,590
ูŠุนู†ูŠ ุจูŠุนู…ู„ูˆุง bone marrow transplantation ูŠุง ุจูŠูƒ
475
00:39:16,590 --> 00:39:21,530
ุจู†ูƒูˆู† ุฃู†ู‡ูŠู†ุง ุงู„ู…ุญุงุถุฑุฉ ุงู„ู€ Milo dysplasia ู†ุชู…ู†ู‰ ุฃู†
476
00:39:21,530 --> 00:39:25,550
ุชูƒูˆู†ูˆุง ู‚ุฏ ุงุณุชูุฏุชู… ูˆ ูู‡ู…ุชู… ูˆ ุดูƒุฑุง